Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hematopoiesis-related proteins represent a diverse collection of molecular entities that regulate the complex process of blood cell formation from hematopoietic stem cells in the bone marrow. This category includes multiple protein families with distinct but interconnected functions. Key examples include MED12, a mediator complex subunit essential for hematopoietic stem cell development and gene transcription regulation[1]; inflammasomes like NLRP3, NLRP1, and AIM2, which are multi-protein complexes controlling inflammatory responses and cell death during hematopoietic stem cell transplantation[2]; epigenetic regulators such as DNA methyltransferases (DNMT1) and histone modifying enzymes that control gene expression patterns during blood cell differentiation[3]; and various signaling molecules including cytokines, chemokines, and their receptors that coordinate stem cell mobilization and immune responses. These proteins are implicated in numerous hematologic malignancies and represent therapeutic targets for leukemia, lymphoma, and complications of stem cell transplantation. Their dysregulation through mutations, hyperactivation, or loss of function can trigger various cancers and hematologic disorders, making them attractive candidates for targeted therapies.
Epigenetic modification (DNA methylation, histone acetylation/deacetylation); Inflammasome inhibition; Cytokine signaling modulation; Stem cell mobilization regulation; Gene transcription regulation; Pyroptosis and apoptosis pathway modulation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hematopoiesis-related proteins (None).